AJANTA PHARMA
Back to Balance Sheet
|
AJANTA PHARMA Last 5 Year Total Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Current Liabilities | ₹996 Cr | ₹895 Cr | ₹1,139 Cr | ₹647 Cr | ₹839 Cr |
What is the latest Total Current Liabilities ratio of AJANTA PHARMA ?
| Year | Total Current Liabilities |
|---|---|
| Mar2025 | ₹996 Cr |
| Mar2024 | ₹895 Cr |
| Mar2023 | ₹1,139 Cr |
| Mar2022 | ₹647 Cr |
| Mar2021 | ₹839 Cr |
How is Total Current Liabilities of AJANTA PHARMA Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹996 Cr | 11.27 | |
| Mar2024 | ₹895 Cr | -21.42 | |
| Mar2023 | ₹1,139 Cr | 75.98 | |
| Mar2022 | ₹647 Cr | -22.82 | |
| Mar2021 | ₹839 Cr | - | |
Compare Total Current Liabilities of peers of AJANTA PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| AJANTA PHARMA | ₹35,125.6 Cr | 1.5% | -3.2% | 7.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹408,439.0 Cr | 6.8% | -1.5% | -2.4% | Stock Analytics | |
| DIVIS LABORATORIES | ₹162,903.0 Cr | 0% | -4.8% | 8.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹134,466.0 Cr | 1.7% | 4.1% | 20.5% | Stock Analytics | |
| CIPLA | ₹107,653.0 Cr | 0.1% | -12.8% | -9.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,924.0 Cr | 1.8% | -0.7% | 3.4% | Stock Analytics | |
AJANTA PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| AJANTA PHARMA | 1.5% |
-3.2% |
7.6% |
| SENSEX | 1.3% |
-2.5% |
8.5% |
You may also like the below Video Courses